Re: A lesson on futility analyses from the CETP inhibitors
|
3
|
Resverlogix Corp.
|
May 11, 2017 11:29AM
|
Re: A new day for RVX
|
6
|
Resverlogix Corp.
|
May 13, 2021 10:42AM
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
3
|
Resverlogix Corp.
|
Jan 08, 2021 07:30PM
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
1
|
Zenith Epigenetics
|
Apr 18, 2020 10:00AM
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
1
|
Zenith Epigenetics
|
Apr 19, 2020 07:35PM
|
Re: AAIC and MD&A
|
6
|
Resverlogix Corp.
|
Jul 24, 2018 08:34AM
|
Re: Add one to the list
|
2
|
Zenith Epigenetics
|
Sep 12, 2023 07:21PM
|
Re: Add one to the list
|
4
|
Zenith Epigenetics
|
Sep 13, 2023 10:17AM
|
Re: Additional Exempt Distribution
|
4
|
Zenith Epigenetics
|
Dec 04, 2023 09:18AM
|
Re: Additional Exempt Distribution
|
5
|
Zenith Epigenetics
|
Dec 06, 2023 11:28AM
|
Re: Additional Exempt Distribution- 2023-03-31
|
4
|
Zenith Epigenetics
|
Apr 15, 2023 03:53PM
|
Re: Additional Exempt Distribution- 2023-03-31
|
4
|
Zenith Epigenetics
|
Apr 16, 2023 07:45PM
|
Re: Additional Exempt Distribution- 2023-03-31
|
2
|
Zenith Epigenetics
|
Apr 17, 2023 07:01AM
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 22, 2023 07:54AM
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 25, 2023 07:00AM
|
Re: Age, MoCA and CKD
|
5
|
Resverlogix Corp.
|
Nov 19, 2019 02:59PM
|
Re: AGM
|
2
|
Resverlogix Corp.
|
Jun 20, 2023 11:45AM
|
Re: Agm
|
2
|
Resverlogix Corp.
|
Dec 13, 2017 12:48PM
|
Re: AGM & PP
|
2
|
Resverlogix Corp.
|
Nov 24, 2020 03:35PM
|
Re: AGM & PP
|
5
|
Resverlogix Corp.
|
Nov 23, 2020 12:38PM
|